NEW YORK – With recent deals in the UK and the US for its artificial intelligence-based Galen digital pathology platform, Ibex Medical Analytics expects the continued adoption of its technology by ...

NEW YORK – Researchers from the US Centers for Disease Control and Prevention have developed a method to test for newborns for homocystinuria, a condition that can lead to permanent damage or death ...

The Ireland-based firm said its inexpensive capacitance-based assays deliver "molecular detection by proxy," providing rapid, ...

Formerly known as Spartan Bioscience, Ottawa, Canada-based Genomadix expects to now commercialize the system and test in the US to guide therapy decisions.

Formerly known as Spartan Bioscience, Ottawa, Canada-based Genomadix expects to now commercialize the system and test in the US to guide therapy decisions.

Produced by Roche, the test measures phosphorylated tau 181 protein and apolipoprotein E4 to help determine if an individual's is at high risk of Alzheimer's.

The agreement gives CND access to technologies key to CND's skin biopsy-based test for the hallmarks of the synucleinopathy family of neurodegenerative diseases.

Thermo Fisher has laid off nearly 400 California employees at sites associated with Mesa Biotech, acquired in 2021 for $450 million in cash.

The nucleic acid amplification test returns results in 25 minutes and is authorized for use in professional point-of-care settings.

The company hopes to build prospective clinical utility evidence for the Esopredict test, its first clinical assay, to support future reimbursement.

Invitae said results from its genetic tests would be made available directly to healthcare providers using Epic's electronic medical record systems.

Last week, readers were most interested in a story about moves by the FDA to regulate LDTs, which could result in legal actions.